Literature DB >> 20736973

Distinguishing the 4qA and 4qB variants is essential for the diagnosis of facioscapulohumeral muscular dystrophy in the Chinese population.

Zhi-Qiang Wang1, Ning Wang, Silvere van der Maarel, Shen-Xing Murong, Zhi-Ying Wu.   

Abstract

Facioscapulohumeral muscular dystrophy (FSHD) is the third most common inherited muscular dystrophy with markedly clinical variability and complex genetic cause. Several reports pertaining to the Caucasian population have confirmed that there are 4qA and 4qB variants of the 4qter subtelomere, and FSHD is uniquely associated with the 4qA variant. However, few data relevant to the Chinese population have been published. In present paper, detailed clinical and genetic re-evaluations were performed in members of four special families who had been initially diagnosed as atypical or asymptomatic FSHD based only on the D4Z4 repeat length analysis. The FSHD-sized D4Z4 repeats in the probands from families 1, 2 and 3 were identified as 4qB variants. These patients were further confirmed as limb-girdle muscular dystrophy (LGMD2) or myotonic dystrophy (DM1) by molecular analyses. Specifically, we identified a 4qB variant on chromosome 10 in the healthy members of the fourth FSHD family with complex D4Z4 rearrangements of two exchanged repeat arrays. For the first time, we demonstrated in the Chinese population that D4Z4 contractions on the 4qB variant do not cause FSHD and 4qB variant on chromosome 10 might also represent intermediate structures in the transition from 4q to 10q. Furthermore, our results emphasize that D4Z4 repeat length analysis alone is not sufficient for the diagnosis of FSHD, especially when used as an exclusion criterion. This analysis should be accompanied by 4qA/4qB variant determination and integrated chromosome assignments, especially in patients with obscure and unclassified myopathies similar to atypical forms of FSHD.

Entities:  

Mesh:

Year:  2010        PMID: 20736973      PMCID: PMC3039510          DOI: 10.1038/ejhg.2010.143

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  21 in total

1.  Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere.

Authors:  Richard J L F Lemmers; Peggy de Kievit; Lodewijk Sandkuijl; George W Padberg; Gert-Jan B van Ommen; Rune R Frants; Silvère M van der Maarel
Journal:  Nat Genet       Date:  2002-09-23       Impact factor: 38.330

2.  D4F104S1 deletion in facioscapulohumeral muscular dystrophy: phenotype, size, and detection.

Authors:  R J L F Lemmers; M Osborn; T Haaf; M Rogers; R R Frants; G W Padberg; D N Cooper; S M van der Maarel; M Upadhyaya
Journal:  Neurology       Date:  2003-07-22       Impact factor: 9.910

3.  FSHD in Chinese population: characteristics of translocation and genotype-phenotype correlation.

Authors:  Zhi-Ying Wu; Zhi-Qiang Wang; Shen-Xing Murong; Ning Wang
Journal:  Neurology       Date:  2004-08-10       Impact factor: 9.910

4.  FSH dystrophy 4q35 deletion in patients presenting with facial-sparing scapular myopathy.

Authors:  K J Felice; W A North; S A Moore; K D Mathews
Journal:  Neurology       Date:  2000-05-23       Impact factor: 9.910

5.  44th ENMC International Workshop: Facioscapulohumeral Muscular Dystrophy: Molecular Studies 19-21 July 1996, Naarden, The Netherlands.

Authors:  P W Lunt
Journal:  Neuromuscul Disord       Date:  1998-04       Impact factor: 4.296

6.  Clinical predominance of proximal upper limb weakness in CMT1A syndrome.

Authors:  M Auer-Grumbach; K Wagner; S Strasser-Fuchs; W N Löscher; F Fazekas; M Millner; H P Hartung
Journal:  Muscle Nerve       Date:  2000-08       Impact factor: 3.217

7.  Extension of the clinical range of facioscapulohumeral dystrophy: report of six cases.

Authors:  A J van der Kooi; M C Visser; N Rosenberg; R van den Berg-Vos; J H Wokke; E Bakker; M de Visser
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-07       Impact factor: 10.154

8.  Atypical phenotypes in patients with facioscapulohumeral muscular dystrophy 4q35 deletion.

Authors:  Michael Krasnianski; Katharina Eger; Stephan Neudecker; Sibylle Jakubiczka; Stephan Zierz
Journal:  Arch Neurol       Date:  2003-10

9.  Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype.

Authors:  E Ricci; G Galluzzi; G Deidda; S Cacurri; L Colantoni; B Merico; N Piazzo; S Servidei; E Vigneti; V Pasceri; G Silvestri; M Mirabella; F Mangiola; P Tonali; L Felicetti
Journal:  Ann Neurol       Date:  1999-06       Impact factor: 10.422

10.  Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex.

Authors:  A A Hack; M Y Lam; L Cordier; D I Shoturma; C T Ly; M A Hadhazy; M R Hadhazy; H L Sweeney; E M McNally
Journal:  J Cell Sci       Date:  2000-07       Impact factor: 5.285

View more
  5 in total

Review 1.  Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence.

Authors:  Silvère M van der Maarel; Rabi Tawil; Stephen J Tapscott
Journal:  Trends Mol Med       Date:  2011-02-01       Impact factor: 11.951

2.  New Insights into Genotype-phenotype Correlations in Chinese Facioscapulohumeral Muscular Dystrophy: A Retrospective Analysis of 178 Patients.

Authors:  Feng Lin; Zhi-Qiang Wang; Min-Ting Lin; Shen-Xing Murong; Ning Wang
Journal:  Chin Med J (Engl)       Date:  2015-07-05       Impact factor: 2.628

3.  Prevalence and disease progression of genetically-confirmed facioscapulohumeral muscular dystrophy type 1 (FSHD1) in China between 2001 and 2020: a nationwide population-based study.

Authors:  Zhiqiang Wang; Liangliang Qiu; Minting Lin; Long Chen; Fuze Zheng; Lin Lin; Feng Lin; Zhixian Ye; Xiaodan Lin; Junjie He; Lili Wang; Xin Lin; Qifang He; Wanjin Chen; Yi Lin; Ying Fu; Ning Wang
Journal:  Lancet Reg Health West Pac       Date:  2021-11-22

4.  A "Triple Trouble" Case of Facioscapulohumeral Muscular Dystrophy Accompanied by Peripheral Neuropathy and Myoclonic Epilepsy.

Authors:  Xiao-Dan Lin; Jun-Jie He; Feng Lin; Hai-Zhu Chen; Liu-Qing Xu; Wei Hu; Nai-Qing Cai; Min-Ting Lin; Ning Wang; Zhi-Qiang Wang; Guo-Rong Xu
Journal:  Chin Med J (Engl)       Date:  2018-09-20       Impact factor: 2.628

5.  Single-molecule optical mapping enables quantitative measurement of D4Z4 repeats in facioscapulohumeral muscular dystrophy (FSHD).

Authors:  Yi Dai; Pidong Li; Zhiqiang Wang; Fan Liang; Fan Yang; Li Fang; Yu Huang; Shangzhi Huang; Jiapeng Zhou; Depeng Wang; Liying Cui; Kai Wang
Journal:  J Med Genet       Date:  2019-09-10       Impact factor: 6.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.